Low platelet counts in cancer patients: Should heparin for venous thromboembolism prophylaxis be instituted? Reply

被引：0
|
作者：
Khorana, Alok A. [1 ]
Francis, Charles W. [2 ]
Falanga, Anna [3 ]
Lyman, Gary H. [4 ]
机构：
[1] Univ Rochester, Sch Med, Dept Med, Rochester, NY 14642 USA
[2] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA
[3] United Hosp Bergamo, Dept Hematol Oncol, Bergamo, Italy
[4] Duke Univ, Dept Med, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 11期
关键词：
D O I：
10.1200/JCO.2008.16.0887
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1906 / 1907
页数：2
相关论文
共 50 条
  • [21] Prophylaxis and treatment of venous thromboembolism in patients with cancer
    Ageno, Walter
    Squizzato, Alessandro
    INTERNAL AND EMERGENCY MEDICINE, 2006, 1 (04) : 260 - 262
  • [22] Prophylaxis and treatment of venous thromboembolism in patients with cancer
    Walter Ageno
    Alessandro Squizzato
    Internal and Emergency Medicine, 2006, 1 : 260 - 262
  • [23] Prophylaxis against venous thromboembolism in patients with cancer
    Verso, Melina
    Agnelli, Giancarlo
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (13): : 1262 - 1262
  • [24] Risk of venous thromboembolism and primary prophylaxis in cancer Should all patients receive thromboprophylaxis?
    Pabinger, I.
    Ay, C.
    HAMOSTASEOLOGIE, 2012, 32 (02): : 132 - 137
  • [25] Evaluation of the use of low-molecular-weight heparin for venous thromboembolism prophylaxis in medical patients
    du Plessis, J. A.
    van Blydenstein, S. A.
    Wong, M.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2020, 110 (03): : 235 - 242
  • [26] A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients
    Gritsiouk, Yaroslav
    Hegsted, Damian A.
    Schlesinger, Piroska
    Gardiner, Stuart K.
    Gubler, Kelly D.
    AMERICAN JOURNAL OF SURGERY, 2014, 207 (05): : 648 - 651
  • [27] Heparin for prophylaxis of venous thromboembolism in intracerebral haemorrhage
    Spruegel, Maximilian I.
    Sembill, Jochen A.
    Kuramatsu, Joji B.
    Gerner, Stefan T.
    Hagen, Manuel
    Roeder, Sebastian S.
    Endres, Matthias
    Haeusler, Karl Georg
    Sobesky, Jan
    Schurig, Johannes
    Zweynert, Sarah
    Bauer, Miriam
    Vajkoczy, Peter
    Ringleb, Peter Arthur
    Purrucker, Jan Christoph
    Rizos, Timolaos
    Volkmann, Jens
    Muellges, Wolfgang
    Kraft, Peter
    Schubert, Anna-Lena
    Erbguth, Frank
    Nueckel, Martin
    Schellinger, Peter D.
    Glahn, Joerg
    Knappe, Ulrich J.
    Fink, Gereon Rudolf
    Dohmen, Christian
    Stetefeld, Henning
    Fisse, Anna Lena
    Minnerup, Jens
    Hagemann, Georg
    Rakers, Florian
    Reichmann, Heinz
    Schneider, Hauke
    Woepking, Sigrid
    Ludolph, Albert C.
    Stosser, Sebastian
    Neugebauer, Hermann
    Roether, Joachim
    Michels, Peter
    Schwarz, Michael
    Reimann, Gernot
    Baezner, Hansjoerg
    Schwert, Henning
    Classen, Joseph
    Michalski, Dominik
    Grau, Armin
    Palm, Frederick
    Urbanek, Christian
    Woehrle, Johannes C.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (07): : 783 - 791
  • [28] ASPIRIN FOR PROPHYLAXIS OF VENOUS THROMBOEMBOLISM - REPLY
    HARRIS, WH
    SALZMAN, EW
    ATHANASOULIS, CA
    WALTMAN, AC
    DESANCTIS, RD
    NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (19): : 1091 - 1092
  • [29] Incidence of Thrombocytopenia among Patients Receiving Heparin Venous Thromboembolism Prophylaxis
    Wang, Tracy Y.
    Honeycutt, Emily F.
    Tapson, Victor F.
    Moll, Stephan
    Granger, Christopher B.
    Ohman, E. Magnus
    AMERICAN JOURNAL OF MEDICINE, 2012, 125 (12): : 1214 - 1221
  • [30] Low-molecular-weight heparin prescribing for venous thromboembolism in cancer patients
    Stewart, David
    Rikhye, Somi
    Odle, Brian
    Flores, Emily
    PHARMACOTHERAPY, 2013, 33 (05): : E51 - E51
12345